The Donor Tracker uses the latest official DAC OECD data for our analyses. The latest full set of data available is 2023. Preliminary data are available on aggregate figures for 2024.
ODA Spending
How much ODA does the EUI allocate to global health?
EU development spending for global health shrank in 2023 from a peak of US$1.9 billion in 2021 as post-pandemic health spending decreased as the war in Ukraine and other challenges emerged and COVID-19 response became less prominent.
How do the EUI allocate global health ODA?
Bilateral Spending
99% of EUI funding for health in 2023 was channeled bilaterally.
Projects related to infectious disease control, basic nutrition, and basic healthcare received the largest shares of the EUI’s bilateral health ODA in 2023. Funding for projects related to COVID-19 control decreased by 300% between 2021 and 2022; while funding for projects related to infectious disease control remained stable.
Multilateral Spending and Commitments
See the table below for a summary of the EUI’s recent multilateral pledges.
‘Break COVID Now’
Funding and Policy Outlook
What is the EUI's current outlook on global health ODA?
Health ODA allocations increased significantly in 2021 in response to the COVID-19 crisis. Because of COVID-19, the EUI has reached its goal of spending at least 20% of the NDICI – Global Europe budget on human development. Approximately 10% is meant to go to education, leaving around 10% for other components of human development, including health and social protection. In addition to the EUI’s funding for global health, the current MFF also has a EUR5.1 billion ( US$6 billion) EU4Health program (2021-2027) of which a maximum of 12.5% of funding will go toward global health initiatives. In February 2024, the EU decided to cut EUR1 billion (US$1.1 billion), 50% of the remaining EU4Health budget to fund more salient priorities, including Ukraine and migration.
In 2022, the European Commission launched the new EU Global Health Strategy, offering a framework for EU health policies leading up to 2030. The strategy builds on the previous strategy from 2010 and aims to expand the EU's international leadership role in global health. It confirms the EU’s support for global health multilaterals, including the WHO, Gavi, and the Global Fund. The three main priorities of the strategy are:
- Delivering better health and well-being of people across the life course;
- Strengthening health systems and advancing universal health coverage; and
- Preventing and combatting health threats, including pandemics, applying a 'One Health' approach
The Strategy has no dedicated budget.
Key Bodies
Global health R&D is also important to addressing many of the global health challenges that disproportionately affect the world’s most disadvantaged people. For more information on how donor countries are supporting global health R&D across three main areas — 1) EIDs; 2) PRNDs; and 3) SRH — read the excellent G-Finder reports and explore the interactive data portal created by Policy Cures Research. Not all funding mentioned in these analyses qualifies as ODA. |
Related Publications
Looking for a cross donor perspective?

Learn more about SEEK's work on global health
Our Experts

Elton Smole

Emily Wymer

Amrithaa Gunabalan

Christina Schrade

Tanvee Kanaujia

Sukhada Bakare

Zachary Abel

Emily Barter

Alexander Doxiadis

Holly Warner
Our Experts
Explore other deep-dives
Read more on Global Health